ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716771 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716771; 2) Community: the network communities that were significantly associated with the response to NSC 716771; 3) Molecule: the relationships between components within communities and NSC 716771; 4) MDR: the compounds that were significantly associated with the NSC 716771.

NSC Compound Enrichment Correlation
NSC 671033 Null 0.0129421834592789 -0.0057130573
NSC 689626 Null 0.0129421834592789 0.32095036
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0129421834592789 0.13546864
NSC 711077 Null 0.0129421834592789 0.18493144
NSC 716503 Null 0.0129421834592789 0.1229216
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.012942183459279 0.022417835
NSC 725098 Null 0.012942183459279 0.27159752
NSC 726217 Combretastatin A4-analogue 0.012942183459279 0.16140083
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.012942183459279 0.081477674
NSC 750873 2,5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-(3-hydroxy-4-methoxyphenyl)-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.012942183459279 0.055318061
Total:83  Current:26    [First] [Prev] [Next] [Last]